Sentences with word «dabigatran»

about Idarucizumab approved as first reversal agent for novel oral anticoagulant dabigatran

There was no significant difference between dabigatran and rivaroxaban in length of stay.

Warfarin users, who were older on average than the other patients and had more co-morbidities, were hospitalized an average of 2 days longer than dabigatran users and 2.6 days longer than rivaroxaban users.

Little is known about the outcomes of bleeding complications during anticoagulant therapy with warfarin in comparison to the newer drugs dabigatran and rivaroxaban, which thin blood more rapidly, but are not easily reversible.

FDA Drug Safety Communication: Safety review of post-market reports of serious bleeding events with the anticoagulant Pradaxa (dabigatran etexilate mesylate), FDA, December 7, 2011

In re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation, MDL No. 2385 (Southern District of Illinois).

Dabigatran persistence and adherence in New Zealand: a nationwide retrospective observational study

Differential Influence of the Antiretroviral Pharmacokinetic Enhancers Ritonavir and Cobicistat on Intestinal P - Glycoprotein Transport and the Pharmacokinetic / Pharmacodynamic Disposition of Dabigatran.

They examined data from November 2010 through March 2014 for 3,144 adult atrial fibrillation patients who were hospitalized for bleeding after starting warfarin (2,446 patients), dabigatran (442 patients) or rivaroxaban (256 patients).

ICU admissions were consistent among the groups, but warfarin use resulted in 3 days longer in the ICU, on average, than dabigatran and 2.4 days longer than rivaroxaban.